Sonoma Pharmaceuticals Posts $7.17 Million in Fiscal Q2 Revenue

Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA) recorded $7.174 million in revenue and a GAAP net loss per share of $0.01 on both a basic and diluted basis for its second fiscal quarter of 2027, which ended Sept. 30, 2026. John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.

BeCrypto News shows a short excerpt and links to the publisher. The full report belongs to TokenPost.